Noesis Capital Mangement Corp Has $15.11 Million Stock Holdings in Agilent Technologies, Inc. $A

Noesis Capital Mangement Corp lifted its position in Agilent Technologies, Inc. (NYSE:A) by 4.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 132,538 shares of the medical research company’s stock after purchasing an additional 6,006 shares during the quarter. Agilent Technologies accounts for approximately 2.2% of Noesis Capital Mangement Corp’s holdings, making the stock its 22nd biggest holding. Noesis Capital Mangement Corp’s holdings in Agilent Technologies were worth $15,107,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Agilent Technologies by 4.3% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock worth $82,712,000 after acquiring an additional 24,687 shares during the last quarter. AIA Group Ltd bought a new position in Agilent Technologies in the 3rd quarter valued at $2,475,000. Massachusetts Financial Services Co. MA raised its position in Agilent Technologies by 13.8% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after purchasing an additional 1,713,216 shares during the last quarter. CCLA Investment Management boosted its stake in Agilent Technologies by 1.9% in the fourth quarter. CCLA Investment Management now owns 1,047,488 shares of the medical research company’s stock worth $142,542,000 after purchasing an additional 19,518 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. boosted its stake in Agilent Technologies by 20.9% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company’s stock worth $7,269,000 after purchasing an additional 9,236 shares in the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and lowered their target price for the company from $150.00 to $145.00 in a research note on Thursday, May 28th. TD Cowen increased their price objective on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Finally, Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Two analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $159.35.

Agilent Technologies Trading Down 0.2%

Shares of A opened at $134.92 on Thursday. The stock’s fifty day simple moving average is $126.82 and its 200-day simple moving average is $125.60. The firm has a market capitalization of $38.11 billion, a PE ratio of 27.09, a price-to-earnings-growth ratio of 2.40 and a beta of 1.25. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same period last year, the company earned $1.31 earnings per share. The company’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, research analysts predict that Agilent Technologies, Inc. will post 6 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be issued a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is currently 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.